JNJNYSE
Johnson & Johnson
Healthcare· Drug Manufacturers - General
www.jnj.com
Earnings2026-10-13in 1mo
$266.35
-$0.73(-0.27%)today
Market Cap641.88B
Key Statistics
52-Week Range
$173.33
$281.07
Current $266.35 · 86% of range
Prev. Close$267.08
Day's High$271.27
Day's Low$265.72
Volume4.84MAvg 7.76M
P/E (TTM)30.97Fwd 21.39
EPS (TTM)$8.60
Div. Yield2.01%$5.36/share
Beta0.23
50D Avg$262.23
200D Avg$236.49
Short % Float1.0%3.3 days to cover
Shares Short21.67M
Price Performance
JNJ
S&P 500
normalized to 0% at period startLatest News
10 articles
JNJ Stock: Is the Rally Running Out of Steam?
Trefis
17h ago
Johnson & Johnson Receives CE Marking for Acuvue Reusable Contact Lenses
MT Newswires
22h ago
The Portfolio You Need to Generate $500 a Month in Dividend Income
24/7 Wall St.
17h ago
HSBC Adjusts Price Target on Johnson & Johnson to $320 From $290, Keeps Buy Rating
MT Newswires
1d ago
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH
Motley Fool
14h ago
Could Icotyde Become Johnson & Johnson’s Next Blockbuster in China?
Insider Monkey
1d ago
AbbVie's Immunology Franchise: From Skyrizi & Rinvoq to What's Next
Zacks
19h ago
Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses
Business Wire
23h ago
Merck Stock Vs. LLY: Why Is The Slower Grower More Expensive?
Trefis
16h ago
Barron’s Got Cooper Wrong but the Contact-Lens Stock Now Looks Cheap
Barrons.com
16h ago
About
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases…